102 related articles for article (PubMed ID: 11754111)
61. Unique de novo mutation of BRCA2 in a woman with early onset breast cancer.
Robson M; Scheuer L; Nafa K; Ellis N; Offit K
J Med Genet; 2002 Feb; 39(2):126-8. PubMed ID: 11836363
[No Abstract] [Full Text] [Related]
62. Deleterious BRCA2 mutation in a 40-year-old woman with inflammatory breast cancer and strong family history of maternal inflammatory breast cancer at a young age.
Morris GJ
Clin Adv Hematol Oncol; 2012 Jun; 10(6):404-5. PubMed ID: 22895247
[No Abstract] [Full Text] [Related]
63. Contribution of BRCA1 germline mutation in patients with sporadic breast cancer.
Malik FA; Ashraf S; Kayani MA; Jiang WG; Mir A; Ansar M; Baloch IA; Sadiq R
Int Semin Surg Oncol; 2008 Aug; 5():21. PubMed ID: 18759965
[TBL] [Abstract][Full Text] [Related]
64. Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.
Margolin S; Johansson H; Rutqvist LE; Lindblom A; Fornander T
Fam Cancer; 2006; 5(4):309-21. PubMed ID: 16858627
[TBL] [Abstract][Full Text] [Related]
65. Are population level familial risks and germline genetics meeting each other?
Hemminki K; Li X; Försti A; Eng C
Hered Cancer Clin Pract; 2023 Mar; 21(1):3. PubMed ID: 36882784
[TBL] [Abstract][Full Text] [Related]
66. EMSY links breast cancer gene 2 to the 'Royal Family'.
Yao J; Polyak K
Breast Cancer Res; 2004; 6(5):201-3. PubMed ID: 15318925
[TBL] [Abstract][Full Text] [Related]
67. Absence of germline prohibitin mutations in early-onset breast-cancer.
Tokino T; Davidson N; Helzlsouer K; Zehnbauer B; Nakamura Y; Vogelstein B; Sidransky D
Int J Oncol; 1993 Oct; 3(4):769-72. PubMed ID: 21573431
[TBL] [Abstract][Full Text] [Related]
68. [Problems in pathologic diagnosis of breast cancer].
Ding HY; Xue WC
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):75-8. PubMed ID: 18681315
[No Abstract] [Full Text] [Related]
69. [Cancer, breast, familial].
Tonoki H
Ryoikibetsu Shokogun Shirizu; 2001; (33):316-7. PubMed ID: 11462455
[No Abstract] [Full Text] [Related]
70. Absence of germline retinoblastoma (Rb) gene mutations in japanese ovarian cancer patients.
Menzin AW
Gynecol Oncol; 1998 Sep; 70(3):441. PubMed ID: 9791190
[No Abstract] [Full Text] [Related]
71. Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non-Hodgkin Lymphoma.
Wang Z; Wilson CL; Armstrong GT; Hudson MM; Zhang J; Nichols KE; Robison LL
JAMA Oncol; 2019 Sep; 5(9):1362-1364. PubMed ID: 31343663
[TBL] [Abstract][Full Text] [Related]
72. Correction to: Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients.
Rashid MU; Muhammad N; Khan FA; Shehzad U; Naeemi H; Malkani N; Hamann U
Hered Cancer Clin Pract; 2021 Jan; 19(1):4. PubMed ID: 33413528
[No Abstract] [Full Text] [Related]
73. Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological Hospitals.
Kaitelidou D; Kalogeropoulou M; Katostaras T; Minogiannis P; Skitsou A; Siskou O; Liaropoulos L
Value Health; 2014 Nov; 17(7):A653-4. PubMed ID: 27202362
[No Abstract] [Full Text] [Related]
74. Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan.
Muhammad N; Azeem A; Arif S; Naeemi H; Masood I; Hassan U; Ijaz B; Hanif F; Syed AA; Yusuf MA; Rashid MU
Hered Cancer Clin Pract; 2023 Nov; 21(1):22. PubMed ID: 37951914
[TBL] [Abstract][Full Text] [Related]
75. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.
Mehrgou A; Akouchekian M
Med J Islam Repub Iran; 2016; 30():369. PubMed ID: 27493913
[TBL] [Abstract][Full Text] [Related]
76. Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis.
Shao J; Yang J; Wang JN; Qiao L; Fan W; Gao QL; Feng YJ
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):629-634. PubMed ID: 26489613
[TBL] [Abstract][Full Text] [Related]
77. Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing.
Tsigginou A; Vlachopoulos F; Arzimanoglou I; Zagouri F; Dimitrakakis C
Hered Cancer Clin Pract; 2015; 13(1):17. PubMed ID: 26300996
[TBL] [Abstract][Full Text] [Related]
78. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Torres-Mejía G; Royer R; Llacuachaqui M; Akbari MR; Giuliano AR; Martínez-Matsushita L; Angeles-Llerenas A; Ortega-Olvera C; Ziv E; Lazcano-Ponce E; Phelan CM; Narod SA
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):498-505. PubMed ID: 25371446
[TBL] [Abstract][Full Text] [Related]
79. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece.
Koumpis C; Dimitrakakis C; Antsaklis A; Royer R; Zhang S; Narod SA; Kotsopoulos J
Hered Cancer Clin Pract; 2011 Nov; 9(1):10. PubMed ID: 22085629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
